01718nam 2200433Ia 450 991069872120332120090424140835.0(CKB)5470000002396647(OCoLC)319169378(EXLCZ)99547000000239664720090424d2008 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] use of nucleic acid tests to reduce the risk of transmission of West Nile virus from donors of whole blood and blood components intended for transfusion and donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps)Rockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2008]i, 12 pages digital, PDF fileTitle from PDF title page (viewed on Apr. 24, 2009)."Draft guidance"."April 2008".Includes bibliographical references (page 12).Guidance for industry Nucleic acidsUnited StatesTestingWest Nile virusUnited StatesPreventionBlood donorsDonation of organs, tissues, etcNucleic acidsTesting.West Nile virusPrevention.Blood donors.Donation of organs, tissues, etc.Center for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698721203321Guidance for industry3434577UNINA